Cancer Network spoke with Ruth Oratz, MD, a medical oncologist at NYU Langone Perlmutter Cancer Center in New York City, about the use of PARP inhibitors for breast cancer.
Ruth Oratz, MD
Advertisement
Articles by Ruth Oratz, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Combatting Toxicities and Leveraging Novel Therapies in Lung Cancer Care
2
Elucidating Treatment Selection for Metastatic HSPC at ASCO GU 2026
3
Acalabrutinib Approval Offers Time-Limited Approach in CLL/SLL
4
Navigating Oligometastasis and Oligoprogression in Stage IV Breast Cancer
5